Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by radaredon Aug 31, 2018 11:28pm

79 Views

Post# 28552128

RE:RE:RE:RE:PP at what's the price

Lets say that the rumor government does hand out a grant for a 2nd phase study for the bladder is true, will we assume that the10m will fund the brain study or is it vice versa, or will it be used for operating budget? Lots of angles to scope here and none give me an adverse reaction more than the clock, a timeline. They could draw this out to 2019 and make all friends and family wealthy. Save the rttry bills passage ( could cause a clambering) nothing to prevent a long wait for the new trials to be sanctioned.

Bullboard Posts

This battery metals stock is on a path to the global stage